Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Volunteer first responders for out-of-hospital cardiac arrest at home: the missing link for improved survival?

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  4. Risk of sports-related sudden cardiac death in women

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  • Task Force for the management of COVID-19 of the European Society of Cardiology
  • Eva Irene Bossano Prescott (Medlem af forfattergruppering)
Vis graf over relationer

AIMS: Since its emergence in early 2020, the novel severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels, and there have been repeated outbreaks across the globe. The aim of this two part series is to provide practical knowledge and guidance to aid clinicians in the diagnosis and management of cardiovascular (CV) disease in association with COVID-19.

METHODS AND RESULTS: A narrative literature review of the available evidence has been performed, and the resulting information has been organized into two parts. The first, which was reported previously, focused on the epidemiology, pathophysiology, and diagnosis of CV conditions that may be manifest in patients with COVID-19. This second part addresses the topics of: care pathways and triage systems and management and treatment pathways, both of the most commonly encountered CV conditions and of COVID-19; and information that may be considered useful to help patients with CV disease (CVD) to avoid exposure to COVID-19.

CONCLUSION: This comprehensive review is not a formal guideline but rather a document that provides a summary of current knowledge and guidance to practicing clinicians managing patients with CVD and COVID-19. The recommendations are mainly the result of observations and personal experience from healthcare providers. Therefore, the information provided here may be subject to change with increasing knowledge, evidence from prospective studies, and changes in the pandemic. Likewise, the guidance provided in the document should not interfere with recommendations provided by local and national healthcare authorities.

OriginalsprogEngelsk
TidsskriftEuropean Heart Journal
Vol/bind43
Udgave nummer11
Sider (fra-til)1059-1103
Antal sider45
ISSN0195-668X
DOI
StatusUdgivet - 14 mar. 2022

Bibliografisk note

This article has been co-published with permission in the European Heart Journal and Cardiovascular Research. © The European Society of Cardiology 2021. All rights reserved. The articles are identical except for minor stylistic and spelling differences in keeping with each journal’s style. Either citation can be used when citing this article.

ID: 74537747